Islet-like clusters derived from mesenchymal stem cells in Wharton's Jelly of the human umbilical cord for transplantation to control type 1 diabetes

PloS One
Kuo Ching ChaoShing Hwa Liu

Abstract

There is a widespread interest in developing renewable sources of islet-replacement tissue for type I diabetes mellitus. Human mesenchymal cells isolated from the Wharton's jelly of the umbilical cord (HUMSCs), which can be easily obtained and processed compared with embryonic and bone marrow stem cells, possess stem cell properties. HUMSCs may be a valuable source for the generation of islets. HUMSCs were induced to transform into islet-like cell clusters in vitro through stepwise culturing in neuron-conditioned medium. To assess the functional stability of the islet-like cell clusters in vivo, these cell clusters were transplanted into the liver of streptozotocin-induced diabetic rats via laparotomy. Glucose tolerance was measured on week 12 after transplantation accompanied with immunohistochemistry and electron microscopy analysis. These islet-like cell clusters were shown to contain human C-peptide and release human insulin in response to physiological glucose levels. Real-time RT-PCR detected the expressions of insulin and other pancreatic beta-cell-related genes (Pdx1, Hlxb9, Nkx2.2, Nkx6.1, and Glut-2) in these islet-like cell clusters. The hyperglycemia and glucose intolerance in streptozotocin-induced diabetic rats wa...Continue Reading

References

Sep 1, 1993·The Journal of Clinical Investigation·T OtonkoskiA Hayek
Jan 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·L DeltourD Bucchini
Jul 8, 2000·Proceedings of the National Academy of Sciences of the United States of America·S Bonner-WeirJ J O'Neil
Dec 20, 2000·Proceedings of the National Academy of Sciences of the United States of America·N UchidaI L Weissman
Jun 6, 2002·Proceedings of the National Academy of Sciences of the United States of America·Lijun YangAmmon B Peck
Nov 21, 2002·Proceedings of the National Academy of Sciences of the United States of America·Yuichi HoriSeung K Kim
Jan 17, 2003·Stem Cells·Kathy E MitchellSatish Medicetty
Mar 18, 2003·The Journal of Clinical Investigation·Andreea IanusMehboob A Hussain
Apr 1, 2003·Nature·George VassilopoulosDavid W Russell
Apr 25, 2003·Nature·Alexander Medvinsky, Austin Smith
Oct 14, 2003·Nature·Manuel Alvarez-DoladoArturo Alvarez-Buylla
Jan 7, 2004·Mechanisms of Development·Alexandra DelacourPedro Luis Herrera
Feb 13, 2004·The New England Journal of Medicine·R Paul Robertson
Mar 23, 2004·Laboratory Investigation; a Journal of Technical Methods and Pathology·Seh-Hoon OhBryon E Petersen
Mar 26, 2004·Transplantation Proceedings·T BerneyP Morel
Mar 27, 2004·BMJ : British Medical Journal·Devasenan DevendraGeorge S Eisenbarth
Aug 19, 2004·Journal of Biomedical Science·Yu-Show FuMing-Yuan Min
Sep 11, 2004·Biochemical and Biophysical Research Communications·Norman EndeAlluru S Reddi
Nov 16, 2004·Biochemical and Biophysical Research Communications·Norman EndeAlluru S Reddi
Dec 8, 2004·Stem Cells·Hwai-Shi WangChin-Chang Chen
Jan 5, 2005·PLoS Medicine·Mark A Naftanel, David M Harlan
Dec 22, 2005·Diabetes, Obesity & Metabolism·Sulaiman A Nanji, A M James Shapiro
Mar 15, 2006·Lancet·Denis Daneman

❮ Previous
Next ❯

Citations

Dec 24, 2010·Regenerative Medicine·Limin WangMichael S Detamore
Jul 23, 2011·Diabetes & Metabolism·A SoggiaB Duvillié
Oct 19, 2011·Journal of Transplantation·Françoise CarlottiEelco J de Koning
Feb 21, 2014·Tissue Engineering. Part B, Reviews·Reine El OmarVeronique Decot
Aug 3, 2010·Stem Cell Reviews and Reports·Cun-Gang FanJing-ru Zhou
Jul 27, 2012·Current Diabetes Reports·Yong Zhao
Apr 28, 2009·Journal of Translational Medicine·Neil H RiordanBoris Minev
Dec 29, 2009·Frontiers in Bioscience (Landmark Edition)·Paras Kumar MishraSuresh C Tyagi
Jun 29, 2011·Molecular Pharmaceutics·Hao WuRam I Mahato
Jun 13, 2012·International Journal of Endocrinology·Feng-Cheng ChouHuey-Kang Sytwu
Sep 13, 2012·Cytotechnology·Paulina DuyaYanjun Zhang
Dec 6, 2008·In Vitro Cellular & Developmental Biology. Animal·Sachin S KadamRamesh R Bhonde
Dec 17, 2009·Current Opinion in Organ Transplantation·Marina VardanyanHoracio L Rodriguez Rilo
Jan 4, 2013·Archivum Immunologiae Et Therapiae Experimentalis·Marta PokrywczynskaTomasz Drewa
Apr 20, 2010·International Archives of Medicine·Thomas E IchimNeil H Riordan
Oct 21, 2015·Best Practice & Research. Clinical Obstetrics & Gynaecology·Marianne S Joerger-MesserliAndreina Schoeberlein
Dec 20, 2014·International Journal of Molecular Sciences·S Suresh KumarAkon Higuchi
Apr 1, 2011·Expert Opinion on Biological Therapy·Jin WangJianming Tan
Jan 23, 2016·Cell and Tissue Research·Pengcheng ZhouZhiwei Wang
May 18, 2013·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Qiping ShiJiye Cai
Nov 7, 2015·Regenerative Medicine·Rasha F El-DemerdashHala O El Mesallamy

❮ Previous
Next ❯

Methods Mentioned

BETA
confocal microscopy
ELISA
electron microscopy
enzyme-linked immunosorbent assay
PCR

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.